Clinical Trials for Previously Treated Myelodysplastic Syndrome

Find clinical trials for previously treated myelodysplastic syndrome. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Personalized NK Cell Therapy in CBT

NCT ID: NCT02727803

This clinical trial is looking at a new treatment called personalized natural killer (NK) cell therapy for patients with certain types of blood cancers, including leukemia, lymphoma, and myelodyspl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

NCT ID: NCT02115295

This clinical trial is investigating a combination of four chemotherapy drugs—cladribine, idarubicin, cytarabine, and venetoclax—to see how well they work in treating patients with certain types of...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

NCT ID: NCT01624805

This clinical trial is exploring the use of a combination of medications to treat patients with aplastic anemia or a type of blood disorder called myelodysplastic syndrome. The medications being st...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

NCT ID: NCT02333162

This clinical trial is investigating a new treatment approach for patients whose blood cancers, like acute myeloid leukemia or myelodysplastic syndrome, have returned after initial treatment. The s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States

A Vaccine (VSV-hIFNβ-NIS) with or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT ID: NCT03017820

This clinical trial is exploring a new treatment option for patients with certain types of blood cancers, including relapsed or hard-to-treat multiple myeloma, acute myeloid leukemia (AML), and var...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions